Multiple sclerosis (MS) is an inflammatory demyelinating and neurodegenerative disease of the central nervous system that is prevalent in young adults and therefore with significant social impact. Cognitive impairment occurs in 40% to 70% of patients with MS and has a weak correlation with disease duration. Neuropsycho-logical assessment is a standard method in the detection of cognitive dysfunction. However, in order to understand the etiology and evolution of cognitive dysfunction, several elaborate magnetic resonance techniques have been developed. Their aim is to measure structural changes in the CNS that are considered main substrates in cognitive function such as whole brain and gray matter atrophy, cortical lesions and changes in subcortical gray matter. Evidence shows that the clinical manifestations of multiple sclerosis are complex interactions between tissue damage, tissue repair and cortical reorganization. In order to study this heterogeneity, structural magnetic resonance analysis of brain morphology and functional magnetic resonance imaging are essential. This review summarizes current techniques in structural MRI and the value of functional MRI in understanding the link between cognitive deficit and cortical activation and reorganization.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. Geurts JJ Barkhof F. Grey matter pathology in multiple sclerosis. Lancet Neurol 2008;7(9):841-51.
2. Messina S Patti F. Gray matters in multiple sclerosis: cognitive impairment and structural MRI. Mult Scler Int 2014;2014:609-94.
3. Chiaravalloti N DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008;7(12): 1139-51.
4. Wattjes MP Geurts JG Barkhof F. Imaging of gray matter lesions in multiple sclerosis. In: Cohen JA Rudick RA eds. Multiple sclerosis therapeutics. 4th Ed. Cambridge University Press; 2011:165-74.
5. Bø L Vedeler CA Nyland HI et al. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003;62(7): 723-32.
6. Filippi M Rocca MA De Stefano N et al. Magnetic resonance techniques in multiple sclerosis: the present and the future. Arch Neurol 2011;68(12): 1514-20.
7. Calabrese M Agosta F Rinaldi F et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing remitting multiple sclerosis. Arch Neurol 2009;66(9):1144-50.
8. Diker S Has AC Kurne A et al. The association of cognitive impairment with gray matter atrophy and cortical lesion load in clinically isolated syndrome. Mult Scler Relat Disord 2016;10:14-21.
9. Geurts JJ Pouwels PJ Uitdehaag BM et al. Intracortical lesions in MS; improved detection with 3D –DIR magnetic resonance imaging. Radiology 2005;236(1):254-60.
10. Fisher E. Measurement of CNS atrophy. In: Cohen JA Rudick RA eds. Multiple sclerosis therapeutics. 4th ed. Cambridge University Press; 2011:128-49.
11. Derakhshan M Caramanos Z Giacomini PS et al. Evaluation of automated techniques for the quantification of grey matter atrophy in patients with MS. Neuroimage 2010;52(4):1261-7.
12. Kunchev T Mehrabian S Raycheva M et al. Cerebral atrophy in relapsing-remitting multiple sclerosis and its relation to cognitive performance. ECTRIMS Online Library. Kunchev T 2016:145802.
13. Kunchev T Fileva M Petrova M et al. Cortical lesions correlate with cortical atrophy and drive cognitive impairment in multiple sclerosis. ECTRIMS Online Library. Kunchev T 2017;199607.
14. Benedict RH Weinstock-Guttman B Fishman I et al. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 2004;61(2):226-30.
15. Benedict RH Bruce JM Dwyer MG et al. Neocortical atrophy third ventricular width and cognitive dysfunction in MS. Arch Neurol 2006;63(9):1301-6.
16. Schoonheim MM Hulst HE Brandt RB et al. Thalamic structure and function determine severity of cognitive impairment in multiple sclerosis. Neurology 201524;84(8):776-83.
17. Roosendal SD Hulst HE Vrenken H et al. Structural and functional hippocampal changes in MS patients with intact memory function. Radiology 2010;255(2):595-604.
18. Filippi M McGowan JC Rocca MA. Measures of magnetization transfer. In: Cohen JA Rudick RA eds. Multiple sclerosis therapeutics. 4th ed. Cambridge University Press; 2011:112-127.
19. Van Waesberghe JH Kamphorst W De Groot CJ et al. Axonal loss in MS lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999;46(5):747-54.
20. Chard D Miller D. Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging. J Neurol Sci 2009;282(1-2):5-11.
21. Ceccarelli A Rocca MA Valsasina P et al. A multiparametric evaluation of regional brain damage in patients with primary progressive multiple sclerosis. Hum Brain Mapp 2009;30(9):3009-19.
22. Bester M Lazar M Petracca M et al. Tract specific white matter correlates of fatigue and cognitive impairment in benign multiple sclerosis. J Neurol Sci 2013;330(1-2):61-6.
23. Kern KC Sicotte NL. Functional imaging in multiple sclerosis. In: Cohen JA Rudick RA eds. Multiple sclerosis therapeutics. 4th ed. Cambridge University Press; 2011:175-85.
24. Rocca MA DeMeo E Filippi M. Functional MRI in investigating cognitive impairment in multiple sclerosis. Acta Neurol Scand 2016;134 Suppl 200:39-46.
25. Lazeron RH Rombouts SA de Sonneville L et al. A paced visual serial addition test for fMRI. J Neurol Sci 2003;213(1-2):29-34.
26. Audoin B Ibarrola D Ranjeva JP et al. Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of multiple sclerosis. Hum Brain Mapp 2003;20(2):51-8.
27. Staffen W Mair A Zauner H et al. Cognitive function and fMRI in patients with MS: evidence for compensatory cortical activation during an attention task. Brain 2002;125(Pt 6):1275-82.
28. Mainero C Caramia F Pozzilli C et al. fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis. Neuroimage 2004;21(3):858-67.
29. Rocca MA Valsasina P Hulst HE et al MAGNIMS fMRI Study Group. Functional correlates of cognitive dysfunction in multiple sclerosis: a multicenter FMRI study. Hum Brain Mapp 2014; 35(12):5799-814.
30. Baltruschat SA Ventura-Campos N Cruz-Gómez ÁJ et al. Gray matter atrophy is associated with functional connectivity reorganization during the PASAT execution in MS. J Neuroradiol 2015;42(3):141-9.